๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

โœ Scribed by Harry LA Janssen; Monika van Zonneveld; Hakan Senturk; Stefan Zeuzem; Ulus S Akarca; Yilmaz Cakaloglu; Christopher Simon; Thomas MK So; Guido Gerken; Robert A de Man; Hubert GM Niesters; Pieter Zondervan; Bettina Hansen; Solko W Schalm


Book ID
117287626
Publisher
The Lancet
Year
2005
Tongue
English
Weight
95 KB
Volume
365
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A viral kinetic study using pegylated in
โœ Vassiliki-Anastasia Sypsa; Konstantinos Mimidis; Nicholas C. Tassopoulos; Dimitr ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 428 KB ๐Ÿ‘ 2 views

We studied viral dynamic parameters in 44 chronic hepatitis B/hepatitis B e antigen (HBeAg)(ุŠ) patients treated with pegylated interferon alfa-2b (PEG-IFN) 100 or 200 g weekly or lamivudine 100 mg daily or the combination of PEG-IFN 100 or 200 g with lamivudine. Patients receiving PEG-IFN monotherap